Evidence map›Paper›PMID 17915572›Full record

SynthesisActa myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology2007

Pharmacological and nutritional treatment trials in McArdle disease.

R M Quinlivan, R J Beynon

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. McArdle Disease: New Insights into Its Underlying Molecular Mechanisms.International journal of molecular sciences · 2019
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

R M QuinlivanThe Wolfson Centre for Inherited Neuromuscular Diseases (CIND), Robert Jones and Agnes Hunt, NHS Trust, Oswestry, UK. Rcmq37@aol.com
R J Beynon
Robert Jones and Agnes Hunt Orthopaedic Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A systematic review of evidence for randomised controlled trials using pharmacologic and nutritional therapies in McArdle disease was undertaken. Primary outcome measures included any objective assessment of exercise endurance. Secondary outcome measures included changes in metabolic parameters, subjective measures such as quality of life scores and adverse outcomes. Ten randomised controlled trials were identified. Two trials low dose creatine (60 mg/kg/day) and oral sucrose 75 g prior to exercise demonstrated a positive effect.

Indexed as

CreatineDouble-Blind MethodGlycogen Phosphorylase, Muscle FormGlycogen Storage Disease Type VHumansMutationRandomized Controlled Trials as TopicRiboseSucroseTreatment OutcomeVitamin B 6CreatineGlycogen Phosphorylase, Muscle FormRiboseSucroseVitamin B 6

Identifiers

PMID17915572
PMCPMC2949313
OpenAlexW2140928356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.